MedTrace Logo

Treatment of Children With ADHD Who do Not Fully Respond to Stimulants

NCT00279409 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-06-19

Study results available
· View outcomes & findings →

Summary

The purpose of this pilot is to initiate a program of research into the development of effective medication techniques to treat those children with ADHD who are referred because they are "partial" or "non-responders" to standard stimulant treatment.

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

DRUG

aripiprazole

double blind capsules (abilify or placebo) taken once daily, up to 10mg.

DRUG

Sugar pill

double blind capsules (abilify or placebo) taken once daily, up to 10mg.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Bristol-Myers Squibb

    collaborator INDUSTRY

  • Otsuka Pharmaceutical Co., Ltd.

    collaborator INDUSTRY

  • New York State Psychiatric Institute

    lead OTHER

Principal Investigators

  • Laurence L Greenhill, MD · New York State Psychiatric Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2008-02-29
Completion
2009-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00279409 on ClinicalTrials.gov